Skip to main content
Free shipping on all orders
888-559-3802
VitabaseIngredients

Polygodial

Table of contents

Other Names

(1R,4aS,8aS)-1,4,4a,5,6,7,8,8a-Octahydro-5,5,8a-trimethyl-1,2-naphthalenedicarboxaldehyde(1R,4aS,8aS)-5,5,8a-Trimethyl-1,4,4a,5,6,7,8,8a-octahydro-1,2-naphthalenedicarbaldehyde(1R,4aS,8aS)-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalene-1,2-dicarbaldehyde(1R,4aS,8aS)-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalene-1,2-dicarboxaldehyde1,2-Naphthalenedicarboxaldehyde, 1,4,4a,5,6,7,8,8a-octahydro-5,5,8a-trimethyl-, (1R,4aS,8aS)-1alpha,4,4aalpha,5,6,7,8,8a-Octahydro-5,5,8abeta-trimethyl-1,2-naphthalenedicarboxaldehydeDrim-7-ene-11,12-dialEpi-polygodialEpipolygodialIsotadeonalPoligodialTadeonal[1R-(1alpha,4abeta,8aalpha)]-1,4,4a,5,6,7,8,8a-Octahydro-5,5,8a-trimethyl-1,2-naphthalenedicarboxaldehyde

Synopsis

Polygodial: A Comprehensive Encyclopedic Reference

1. Identity: Names, Sources, and Forms

Chemical Identity

Polygodial is chemically a drimane-type sesquiterpene dialdehyde with the molecular formula C15H22O2. Its systematic IUPAC name is drim-7-en-11,12-dial (also described as (1R,4aS,8aS)-1,4,4a,5,6,7,8,8a-octahydro-5,5,8a-trimethyl-1,2-naphthalenedicarboxaldehyde). A pungent substance, polygodial is shown to be drim-7-en-11,12-dial (I), a new dialdehyde structurally related to sesquiterpene lactones from Drimys species. It is also known in the literature by the synonym tadeonal, derived from its prominent occurrence in the Japanese culinary plant tade. A bicyclic sesquiterpenoid, polygodial (tadeonal, an unsaturated dialdehyde with a drimane backbone) has been found responsible for the pungent taste of water pepper.

Discovery and First Isolation

Polygodial is a sesquiterpene dialdehyde first isolated from Persicaria hydropiper (syn. Polygonum hydropiper) by Loder at CSIRO, Australia in 1962.

Natural Sources

Polygodial is found in dorrigo pepper, mountain pepper, horopito, canelo, paracress, water-pepper, and Dendrodoris limbata. It belongs to a large family of terpenoids sharing the α,β-unsaturated 1,4-dialdehyde motif, and it has been isolated from a variety of natural sources including terrestrial plants, fungi, algae, liverworts, arthropods, sponges, and molluscs.

Key plant sources include:

  • Persicaria hydropiper (water pepper / tade): Persicaria hydropiper (syn. Polygonum hydropiper), also known as water pepper, marshpepper knotweed, or tade, is a plant of the family Polygonaceae and is a widespread species found in Australia, New Zealand, temperate Asia, Europe and North America. Two bicyclic sesquiterpenoids are present in water pepper: polygodial (tadeonal, an unsaturated dialdehyde with a drimane backbone) and warburganal, which gives it its pungent taste.
  • Pseudowintera colorata (horopito / New Zealand pepper tree): The common names include mountain horopito or pepper tree, also known as the New Zealand pepper tree, winter's bark, or red horopito. Pseudowintera colorata is endemic to New Zealand.
  • Drimys winteri (canelo / Winter's bark): Drimys winteri (Winteraceae) is a tree with medicinal properties native to Chile. Its bark contains polygodial and drimenol in unknown quantities, with antimicrobial and antinociceptive activity. In dried leaves, mean concentrations of 0.99% for polygodial could be observed, differing significantly among studied populations.
  • Tasmannia lanceolata (mountain pepper) and Tasmannia stipitata (dorrigo pepper): Polygodial is a natural sesquiterpene compound isolated from water pepper (Persicaria hydropiper), Dorrigo pepper (Tasmannia stipitata), and mountain pepper (Tasmannia lanceolata).
  • Warburgia spp.: Most of the biological activities attributed to Warburgia are attributed to the drimane sesquiterpenoids, including polygodial, warburganal, muzigadial, mukaadial and ugandensial, flavonoids and miscellaneous compounds present in the various species.
  • Marine invertebrates: Polygodial has also been isolated from marine nudibranchs.
  • Ferns: Some ferns, Blechnum fluviatile collected in New Zealand and Argentinean Thelypteris hispidula, elaborate the pungent component polygodial together with its related drimanes.

Common Forms and Preparations

In commercial and research settings, polygodial is obtained as a purified crystalline compound by solvent extraction from plant material, typically using dichloromethane or hexane/ethyl acetate systems, followed by column chromatography. Polygodial is widely distributed, occurring in the roots, bark, and leaves of several trees, in plants and liverworts, and, more surprisingly, in marine sponges and nudibranches. In the food and spice trade, the compound is encountered as a natural constituent of whole or ground mountain pepper berries, dried water pepper leaves, and related products. As a dietary supplement, it is most often delivered as a standardized bark or leaf extract of Pseudowintera colorata (horopito) or Tasmannia species. Purified polygodial is also available as a research-grade chemical reagent.

2. Traditional and Historical Use

Māori and New Zealand (Pseudowintera colorata — Horopito)

Horopito was used traditionally by Māori for a variety of medicinal purposes including treatment of fungal skin infection, stomach pain, diarrhoea, and as an analgesic.

Mapuche People of Chile (Drimys winteri — Canelo)

Commonly called "Canelo," Drimys winteri is considered the sacred tree for the Mapuche, the largest indigenous group in Chile, who use its leaves or barks to treat injuries and other diseases in healing ceremonies denominated "machitun." The barks of Drimys winteri are used in folk medicine as a remedy to treat several diseases, including dolorous processes. Previous pre-clinical experiments have revealed that the hydroalcoholic extract of this plant showed anti-allergenic, anti-inflammatory, and antinociceptive properties. Drimys winteri, a well-known medicinal plant found in Brazil and some Latin American countries, is commonly used in folk medicine as an anti-inflammatory, antispasmodic, and antipyretic, and for the treatment of asthma, bronchitis, and allergy.

Japan and East Asia (Persicaria hydropiper — Tade / Water Pepper)

In Japan, P. hydropiper is also a popular relish for "sashimi" (raw fish). Persicaria hydropiper has a strong peppery taste and is commonly used as a hot-tasting spice, food flavor, and garnish for a variety of traditional dishes. The Japanese people use the young shoot as a spice and garnish with raw fish such as "sashimi" for its pungent taste, while the water or ethanol leaf extract served as a food additive to preserve pickles, dressing, and cooked foods. Young red sprouts are known as beni-tade (紅蓼) and are used to garnish sashimi, tempura, and sushi. In Japanese culinary tradition, the plant is also incorporated into tade-zu, a tangy sauce made by blending the leaves with vinegar and soy, commonly served as a condiment alongside grilled freshwater fish.

The plant was once used as a pepper substitute in Europe and is still a popular condiment for sashimi in Japan. In Europe, the plant has been used as a diuretic and emmenagogue and to regulate menstrual irregularities. In addition, decoction of the whole plant, either alone or mixed with other medicinal plants, is also given for diarrhea, dyspepsia, itching skin, excessive menstrual bleeding, and hemorrhoids.

Africa (Warburgia species)

The genus Warburgia, a member of the cinnamon family (Canellaceae), has been described as the panacea of Africa. In addition to anti-infective properties, Warburgia extracts are also used to treat a wide range of ailments, including stomach aches, fever, and headaches, which may also be a manifestation of infections. Polygodial is among the principal drimane sesquiterpenoids responsible for these properties. Self-medication by various animals has also been recorded: African elephants in the Kibale forest in Uganda consume the bark of W. ugandensis for this purpose.

Brazil (Drimys brasiliensis and D. angustifolia)

Polygodial is one of the main bioactive compounds in some plants used as food spices and in traditional medicine, such as P. hydropiper in Japan and China, Warburgia spp. in Africa, and Drimys angustifolia in Brazil.

3. Key Constituents, Related Compounds, and Structural Chemistry

Polygodial has been reported to possess biological activities such as antifungal, antibacterial, anti-tumor, larvicidal, antihelminthic, antifouling, anti-inflammatory, analgesic, antitrypanosomal, and antileishmanial activities. As a bioactive constituent, it is produced in several plants of the Canellaceae, Polygonaceae, and Winteraceae families, as well as in marine animals such as sponges and molluscs.

In water pepper (P. hydropiper), polygodial co-occurs with several other phytochemicals. The plant also contains rutin, a source of the bitter taste impression, and an essential oil (0.5%) which consists of monoterpenoids and sesquiterpenoids including α-pinene, β-pinene, 1,4-cineol, fenchone, α-humulene, β-caryophyllene, and trans-β-bergamotene.

In Drimys winteri, polygodial, 1-β-(p-methoxycynnamyl)polygodial, taxifolin, and astilbin are the main components identified in active fractions. The sesquiterpenoids drimenol, polygodial, and isodrimeninol have been isolated from the barks of the Chilean native tree Drimys winteri. In Warburgia species, polygodial co-occurs with warburganal, muzigadial, and ugandensidial — all members of the drimane dialdehyde class.

4. Established Mechanisms of Action

4.1 Activation of TRPA1 Ion Channels (Pungency and Nociception)

Polygodial is a TRPA1 channel activator (EC50 = 400 nM) that is selective against TRPV1, TRPV2, TRPV3, TRPV4, and TRPM8 channels. The compound activates the TRPA1 pain receptor in nerve endings in the mouth that mediate the sensation of pungency. Its characteristic warm and pungent taste thus has a specific molecular basis in TRP channel pharmacology. The compound acts as an analgesic via desensitization of sensory neurons — a pharmacological phenomenon (desensitization/tachyphylaxis) whereby initial activation of nociceptors leads to a subsequent refractory period of reduced pain signaling.

4.2 Voltage-Gated Sodium Channel Inhibition

Drimys winteri, a South American evergreen shrub used by the Mapuche people for treatment of several painful conditions, contains polygodial, a lipophilic drimane-type sesquiterpene dialdehyde with known activity at transient receptor potential channel family members including TRPA1 and TRPV1. Researchers have sought to assess the activity of polygodial at NaV1.7 and NaV1.8, two key isoforms of the voltage-gated sodium channel family involved in nociception. Polygodial has been shown to inhibit members of the voltage-gated sodium channel family. Inhibition of Nav1.7 and Nav1.8 represents a distinct and potentially complementary analgesic mechanism to TRP channel modulation.

4.3 Antifungal Mechanisms

Multiple mechanisms have been proposed for polygodial's antifungal activity. Early work using Saccharomyces cerevisiae as a model showed that the mechanism of polygodial antifungal action was studied using Saccharomyces cerevisiae; it inhibited the incorporation of radioactive precursors into macromolecules in whole cells, but no specificity in the inhibition of precursor incorporation was observed among various species of macromolecules, including DNA, RNA, protein, and polysaccharide. It also inhibited the exogenous but not endogenous respiration of the cells.

More recent genome-wide screening confirmed additional targets: among hypersensitive strains, an enrichment was found for genes required for vacuolar acidification, amino acid biosynthesis, nucleosome mobilization, the transcription mediator complex, autophagy, and vesicular trafficking, while resistant strains were enriched for cytoskeleton-binding proteins, ribosomal proteins, and regulators of TORC1 signaling. Polygodial triggers a dose-dependent vacuolar alkalinization and increases Ca2+ influx, inhibiting glucose-induced Ca2+ signaling. Evidence suggests that TORC1 signaling and ubiquitin play a central role in polygodial resistance.

Polygodial also exhibits antifungal activity via inhibition of mitochondrial ATPase.

4.4 Anti-Inflammatory Mechanisms: NF-κB Pathway

Polygodial and isotadeonal (epi-polygodial), two drimane sesquiterpene dialdehydes, were isolated from Drimys winteri, a medicinal tree of the Mapuche people in Chile. Both sesquiterpenoids were evaluated on the NF-κB pathway, with the result that isotadeonal inhibited the phosphorylation of IκB-α at 10 μM with higher potency by Western blotting. Isotadeonal inhibited SEAP (secreted alkaline phosphatase, a downstream NF-κB reporter) with higher potency than polygodial, quercetin, and CAPE (phenethyl ester of caffeic acid). In silico analysis suggests that the α-aldehyde of isotadeonal adopts a more stable conformation in the active pocket of IκB-α than polygodial.

Drimenol, polygodial, and isodrimeninol reduced the monocyte adhesion to HUVECs (human umbilical vein endothelial cells) at 10 μg/mL. Polygodial and isodrimeninol reduced gene and protein expression of VCAM-1 at 10 μg/mL; Drimys winteri extract and polygodial also reduced the protein expression of ICAM-1 at 10 μg/mL.

4.5 Antitrypanosomal and Antiparasitic Mechanisms

It was proposed that the two sesquiterpene aldehydes warburganal and polygodial formed covalent bonds with amino groups of proteins and thereby affect a vast number of cellular activities — a mechanism consistent with the highly electrophilic nature of the α,β-unsaturated dialdehyde moiety.

4.6 Anticancer Mechanisms

Polygodial robustly inhibits the viability, colony formation, and migration of taxane-resistant CRPC (castration-resistant prostate cancer) cell lines (PC3-TXR and DU145-TXR). Additionally, PG promotes anoikis and induces cell cycle arrest at the G0 phase in PCa cells. Results reveal that PG induces oxidative stress and activates apoptosis in drug-resistant CRPC cell lines, suggesting that the anticancer activity of PG is via the induction of apoptosis in CRPC cells.

5. Scientific Evidence by Area of Use

5.1 Antifungal Activity (Candida and Other Fungi)

Evidence level: Preclinical (in vitro and in vivo animal models); no confirmed human clinical trials.

Polygodial has been tested as a very effective inhibitor of Candida albicans. Researchers isolated polygodial from Warburgia ugandensis Sprague subspecies ugandensis (Canellaceae) and showed its activity against Candida albicans. Specifically, low concentrations of polygodial are not only active against the planktonic forms of C. albicans, but the compound is also active against its biofilm forms.

Research into the antifungal mechanism using genome-wide phenotypic screening in S. cerevisiae showed that the vacuolar ATPase is involved in the antifungal action of polygodial in the model system S. cerevisiae by buffering the cell against a polygodial insult, and the vacuolar pH experiments and Ca2+ measurements further implicate polygodial in affecting this organelle. The proposed target for polygodial may act on TORC1 signaling, either directly or via disturbance of Ca2+ homeostasis.

Studies on agricultural pathogen applications have also been conducted: antifungal effect of polygodial on Botrytis cinerea, a fungal pathogen affecting table grapes, was reported. Polygodial reduces microbial concentration present on shredded lettuce (Forbes-Smith & Paton, 2002). All current antifungal evidence for polygodial against human pathogens remains at the in vitro or preclinical level; no controlled human clinical trials have been published.

5.2 Analgesic and Antinociceptive Effects

Evidence level: Preclinical (animal and cell-based studies); no published human clinical trials.

Polygodial possesses anti-nociceptive effects mediated via inhibition of TRPV1. In parallel, its TRPA1 agonism followed by receptor desensitization provides an additional pharmacological basis for analgesia. The barks of Drimys winteri are used in folk medicine as a remedy to treat several diseases, including dolorous processes. Previous pre-clinical experiments revealed that the hydroalcoholic extract of this plant showed anti-allergenic, anti-inflammatory, and antinociceptive properties.

The voltage-gated sodium channel findings are also relevant to antinociception: polygodial, with known activity at transient receptor potential channel family members including TRPA1 and TRPV1, has been assessed for activity at NaV1.7 and NaV1.8, two key isoforms of the voltage-gated sodium channel family involved in nociception, and was found to inhibit members of this family. The analgesic evidence thus rests on multiple complementary mechanisms, all demonstrated at the preclinical level.

5.3 Anti-Inflammatory Activity

Evidence level: Preclinical (cell-based and in vitro); no published human clinical trials.

Drimane sesquiterpenoids could be used as a molecular scaffold in the development of drugs for inflammatory vascular diseases. At 10 μg/mL, polygodial reduced monocyte adhesion to stimulated human endothelial cells and downregulated VCAM-1 and ICAM-1 expression — both key mediators of the inflammatory cascade in atherosclerosis and other vascular inflammatory conditions. The NF-κB pathway inhibition at 10 μM provides another cell-based mechanistic link. These remain in vitro findings with no published controlled human trials.

5.4 Antiparasitic Activity (Trypanosomiasis and Leishmaniasis)

Evidence level: Preclinical (in vitro and animal models).

The drimane sesquiterpene dialdehyde polygodial, from Drimys (Winteraceae) species, was reported to possess activity against T. cruzi trypomastigotes with an IC50 value of 2.03 μg/mL, and was found 19-fold more active than benznidazole in this in vitro assay. Out of 40 plant extracts tested, the DCM extract from stem bark of Warburgia salutaris (used against many pathologies in Africa) exhibited the most potent trypanocidal activity, and the trypanocidal activity was suggested to be due to the drimane sesquiterpenoids warburganal and polygodial. No human clinical trial evidence is available; these findings are limited to laboratory and animal studies.

5.5 Anticancer Activity

Evidence level: Preclinical only (in vitro cell-line studies); no published human clinical trials.

Polygodial is a natural sesquiterpene compound isolated from water pepper, Dorrigo pepper, and mountain pepper, which has shown anticancer properties. Polygodial robustly inhibits the viability, colony formation, and migration of taxane-resistant CRPC (PC3-TXR and DU145-TXR) cell lines. In both cell lines, the half maximal inhibitory concentration (IC50) is 20 µM, and the maximum inhibition of cell viability by PG is observed at 50 µM.

A 2018 PMC study examined a synthetic analog, DRP-27: researchers evaluated the anti-cancer activity of a new PG derivative, DRP-27, against androgen-sensitive human prostate cancer cells (LNCaP), and cell viability analysis indicated that PG derivatives showed more pronounced anti-proliferative activity than the parent PG, with DRP-27 being the most potent. Levels of reactive oxygen species were significantly increased in a dose-dependent manner in DRP-27–treated cells; the intracellular reactive oxygen species appears to be critical for DRP-27-induced cell death in LNCaP cells, because oxidative stress is implicated in many biological processes such as cell cycle arrest, DNA damage, and apoptosis.

Warburganal, polygodial, and muzikadial have also been demonstrated to exhibit strong cytotoxicity against cancer cell lines. All anticancer data for polygodial currently come from cell-line studies; no animal tumor models or human clinical trials have been published for polygodial itself.

5.6 Insect Antifeedant and Insecticidal Activity

The drimane sesquiterpenes drimenin, drimenol, and polygodial were isolated as the major components in the extract from D. winteri. The purified compounds displayed insecticidal activity against Sitophilus granarius in a concentration/time-dependent manner, with polygodial at 0.5% w/w over 6 days achieving 80% mortality. A significant amount of early biological investigations involving these dialdehydes focused on their hot taste to the human tongue and antifeedant activities, both of which appeared to depend on the configuration of the aldehyde group at C9.

5.7 Antibacterial Activity

Evidence level: Preclinical (in vitro); no published human clinical trials.

Polygodial has potent antibiotic, antifungal, and insecticidal activity, and exhibits cytotoxic, anti-inflammatory, and glucocorticoid activities. Isolation from Warburgia species has revealed activity against respiratory pathogens in vitro: noteworthy activity was observed against M. catarrhalis with an MIC of 31 μg/mL, and polygodial showed an MIC of 25 μg/mL against K. pneumoniae. These results are limited to in vitro minimum inhibitory concentration (MIC) assays and have not been validated in clinical settings.

6. Body Systems and Health Areas Associated with Polygodial

  • Nervous system / Pain: Analgesic and antinociceptive properties via TRPA1 desensitization, TRPV1 modulation, and NaV1.7/1.8 inhibition.
  • Immune and inflammatory system: Inhibition of NF-κB pathway, reduction of VCAM-1 and ICAM-1 expression, inhibition of monocyte adhesion to endothelial cells.
  • Gastrointestinal system: Traditional use in diarrhea, dyspepsia, and as a food preservative; modern research on Candida biofilm in the gastrointestinal environment.
  • Cardiovascular system: Endothelial cell adhesion molecule downregulation relevant to atherosclerotic disease.
  • Oncology (preclinical): Apoptosis induction and cell cycle arrest in prostate cancer cell lines, including drug-resistant CRPC models.
  • Infectious disease (preclinical): Antifungal activity against Candida spp., antibacterial effects in vitro; antitrypanosomal and antileishmanial activity in vitro.
  • Respiratory system: Traditional use for asthma and bronchitis (Drimys winteri); polygodial identified in bark extracts used as inhalation therapy for respiratory ailments.

7. Dosage Forms and Reported Dosages

There are no established clinical or pharmacopoeial dosages for isolated polygodial in human populations, as no controlled human clinical trials have been published. All dosages below are from preclinical studies or toxicological research as reported in the scientific literature.

  • In vitro cell viability (prostate cancer cell lines): The half maximal inhibitory concentration (IC50) in taxane-resistant CRPC cell lines is 20 µM, and the maximum inhibition of cell viability is observed at 50 µM.
  • In vitro antifungal (Candida / Warburgia-derived): Polygodial showed activity against C. albicans at concentrations in the range of 75–125 μg/mL (IC50 values, depending on the derivative and strain; referenced in in silico and in vitro molecular studies).
  • In vitro anti-inflammatory (endothelial cells): Drimenol, polygodial, and isodrimeninol reduced monocyte adhesion to HUVECs at 10 μg/mL.
  • In vitro NF-κB inhibition: Isotadeonal inhibited the phosphorylation of IκB-α at 10 μM; polygodial showed activity at the same concentration, albeit with lower potency.
  • TRPA1 activation (receptor pharmacology): EC50 = 400 nM for TRPA1 channel activation.
  • Rat subchronic toxicology (water pepper extract, WPE): The no-observed-adverse-effect level (NOAEL) of water pepper extract (WPE) was 1,000 ppm, which corresponds to 57.4 and 62.9 mg/kg/day for male and female rats, respectively (Kuroiwa et al., 2006).
  • Antitrypanosomal (in vitro): Polygodial from Drimys species possessed activity against T. cruzi trypomastigotes with IC50 = 2.03 μg/mL, and was found 19-fold more active than benznidazole.

8. Safety Considerations

8.1 Known Toxicological Findings (Preclinical)

At the highest doses tested in rats, slight increases of blood urea nitrogen in both sexes, and of serum alanine aminotransferase, Na, and Cl in females were observed; these increases are suggestive of weak hepatic and renal toxicity, at least in females. The same females also exhibited slight decreases in the number of red blood cells and haematocrit, slight increases in mean corpuscular volume and mean corpuscular haemoglobin, and minimal increases of splenic haemosiderin deposition, providing evidence of slight haemolytic anemia.

An enhanced mast cell accumulation in the mesenteric lymph nodes induced by water pepper extract (WPE) treatment might be related to the complex biological effects of polygodial and/or related ingredients included in this extract on the gastrointestinal environment.

8.2 Mutagenicity

Polygodial was demonstrated to produce no mutagenicity at concentrations below toxicity (Anke and Sterner, 1991).

8.3 Skin Irritation

Some people experience mild contact dermatitis or "smarting" of the skin when handling the crushed leaves of water pepper, so gloves are recommended for weeding. This skin-irritant property is consistent with the TRPA1-activating mechanism of polygodial.

8.4 Livestock Toxicity

In large quantities, water pepper can be toxic to livestock, causing digestive upset and skin sensitivity to sunlight (photosensitization).

8.5 Pregnancy

Although the toxicity of Warburgia (a primary polygodial-containing genus) remains poorly investigated, it has been contra-indicated in pregnancy.

8.6 Electrophilic Reactivity and Protein Binding

The α,β-unsaturated dialdehyde structure of polygodial renders it a highly reactive electrophile capable of forming covalent bonds with nucleophilic amino acid residues (e.g., lysine, cysteine) in proteins. It was proposed that the sesquiterpene aldehyde polygodial forms covalent bonds with amino groups of proteins and thereby affects a vast number of cellular activities. This broad protein-reactive profile underlies both the biological potency and the potential for non-specific cellular toxicity at higher concentrations, and is a key consideration in any assessment of safety margins.

8.7 Absence of Clinical Safety Data

No published peer-reviewed human clinical safety studies specifically for isolated polygodial as a dietary supplement were identified. Safety inferences must therefore be drawn from the NOAEL established in rat subchronic studies, from the long history of dietary exposure via P. hydropiper and Tasmannia-based spices, and from cell-line cytotoxicity data. The gap between in vitro concentrations showing anticancer effects (IC50 20 µM) and safe dietary exposure levels has not been formally bridged in any published human pharmacokinetic study.

References

Health Conditions

Health conditions that Polygodial may help support.

  • No conditions available.

Body Systems

Body systems that Polygodial may help support.

  • No body systems available.
Join our newsletter

Stay informed. Stay healthy.

Get expert supplement tips, exclusive discounts, and product recommendations delivered to your inbox